MYC and primary cutaneous T-cell non-Hodgkin lymphoma: Recently, we have shown that miR-34a can control miR-16 as well as p21 via targeting of HDAC1 and c-Myc in NSCLC and cutaneous T-cell lymphoma (CTCL) [17].